EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for HLSQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -3.658
March 31, 2026 -73.83
December 31, 2025 -83.69
September 30, 2025 -55.46
June 30, 2025 -36.64
March 31, 2025 -62.99
December 31, 2024 -151.70
September 30, 2024 58.82
June 30, 2024 -130.74
March 31, 2024 -528.50
December 31, 2023 -226.90
September 30, 2023 -247.93
June 30, 2023 -236.28
March 31, 2023 -376.22
December 31, 2022 -373.06
September 30, 2022 -430.73
Date Value
June 30, 2022 -477.45
March 31, 2022 -521.64
December 31, 2021 -697.40
September 30, 2021 -703.86
June 30, 2021 -573.12
March 31, 2021 -666.69
December 31, 2020 -749.70
September 30, 2020 -725.12
June 30, 2020 -513.36
March 31, 2020 -489.65
December 31, 2019 -772.86
September 30, 2019 -3976.17
June 30, 2019 -600.00
March 31, 2019 -3056.04
December 31, 2018 -356.61
September 30, 2018 -3037.09

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
Anika Therapeutics, Inc. 0.2412
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412